Medivizor News
12 articlesMy Personal Therapeutics and Medivizor Announce a Collaboration Agreement
growth-positive
MedEvoke and Medivizor Sign Multi-Year Agreement to Streamline Clinical Trial Recruitment Efforts for Pharmaceutical, Biotechnology and Medical Device Clients
MedEvoke, a premier provider of Medical Affairs and Clinical Trial solutions, has partnered with Medivizor to improve patient recruitment and retention in clinical research studies. The combination of Medivizors patient communities and personalized content with MedEvokes analytics and tactical approach aims to find the right patients for each trial. The partnership is expected to accelerate recruitment and shorten the time it takes to find eligible patients. MedEvoke specializes in data analysis, cross-functional engagement, and seamless evolution of narrative, while Medivizor empowers patients by providing them with personalized medical science. The joint offering will benefit both trial sponsors and patients.
Partners
growth-positive
Medivizor uses AI to put patients in the driver's seat
Medivizor CEO Tal Givoly discusses how his startup distills cutting-edge medical science to patients at MEDinIsrael 2019.
CustomersPartners
growth-positive
Innovation Celebrated at GIANT Health Event with Beanstalks Competition
Five start-ups were celebrated in the Beanstalks healthtech competition at the GIANT Health Event. The winners in different categories were Memory Tracks, Activate for Health, Corthotec Ltd, Select Research Ltd, and MedicSpot. Each winner received various prizes and packages to support their businesses. The event attracted a total of 133 entries, with 18 pitching at the GIANT Health Event. Beanstalks aims to assist and advance innovative healthtech enterprises.
Customers
growth-positive
Personalized, cutting-edge, health information - Medivizor
The article promotes Medivizor as a go-to-source for personalized health information. It highlights how Medivizor scans medical literature, clinical trials, and guidelines to deliver relevant information to users. The impact on the company is growth-positive as it positions Medivizor as a valuable resource for individuals seeking health information online. The key theme of the article is the provision of personalized and clinically relevant medical science. The key issue discussed is the acquisition of new customers. No specific partners, customers, valuation amount, acquisition amount, investment amount, layoffs, or date of the event are mentioned in the article. Confidence level: 8/10.
Customers
growth-positive
Goodbye Dr. Google, hello Medivizor
Israeli company Medivizor uses patent-pending technology to provide personalized and relevant medical information to individuals. The companys software, crowdsourcing techniques, and medical expertise help users access easy-to-read and customized information. Medivizor has won several competitions and is promoted by doctors and medical institutions. The company generates revenue from health institutions and ensures user privacy. Medivizor aims to help millions of people coping with serious or chronic illnesses by providing cutting-edge science in medicine.
Customers
growth-positive
mHealth Announces Finalists In Mobile Health Startup Competition
mHealth Israel announced the finalists in its startup competition, with the winner receiving funding from OurCrowd and services worth $10,000. The judgement panel includes representatives from Microsoft, Walgreens, Sony, Orange, and more. The startups selected for the final round are BreezoMeter, Voiceitt, Medivizor, Lifegraph, Myndlift, Sweetch, mPharma, and Intendu.
Investment
growth-positive
Website provides free personalized medical information for common conditions - The Boston Globe
Medivizor is a free website that provides personalized medical information to patients. It uses an algorithm to select the most relevant clinical reports for each patient based on their medical profile. The website offers summaries written in simple language and provides key insights about conditions and treatments. Medivizor currently focuses on the five most common types of cancer, diabetes, heart disease, and infertility. Patients and caregivers find the website useful for exploring treatment options and gaining a deeper understanding of their diagnosis. The site is recommended by physicians and allows patients to share information with their doctors. Medivizor plans to expand to include other conditions in the future.
Customers
Medivizor Sends You and Your Doctor Personalized Health Information
N/A
Xconomy: Medivizor Takes on WebMD, Dr. Google, With Customized Health Service
The article does not provide any specific information about the company or any events.
Medivizor Makes its Health Information Service Available to the Public
growth-positive
Startup of the week / Medivizor, your personal medical consultant
Medivizor is a startup that provides exact, reliable, and personalized medical information to individuals with serious or chronic diseases. The company aims to address the inefficiencies in the process of searching for disease-related information by offering tailored information that meets the users condition and needs. Medivizor focuses on diseases like prostate cancer, breast cancer, diabetes, and colorectal cancer, and plans to expand to other diseases based on user needs. The service is currently available in English but will be offered in other languages in the future. Medivizor sources information from professional scientific journals and sends updates to users based on their preferences. The company, founded in 2011, has about 15 employees and raised its first capital in 2012. Crowdsourcing and expert oversight are used to ensure the accuracy and quality of the information provided.
Customers